Nuburu received delisting notice from NYSE American over low stock price
Nuburu received a notice on July 17, 2026 from NYSE American that the exchange had commenced delisting proceedings because the company's common stock traded below $0.10, violating Section 1003(f)(v) of the NYSE American Company Guide. The company said it intends to request a review hearing, appeal the decision, and implement a reverse stock split (for which it has already obtained stockholder approval) to regain compliance. The notice came the same day Nuburu closed a $38.0 million public offering.
Key facts
- On July 17, 2026, NYSE American commenced delisting proceedings due to common stock trading below $0.10
- Violation of Section 1003(f)(v) of the NYSE American Company Guide cited as reason
- Company intends to request review by Listings Qualifications Panel and appeal the decision
- Company plans to implement reverse stock split to regain compliance; stockholder approval already obtained
- Offering of 117,365,368 common shares and 127,007,616 pre-funded warrant shares closed July 17, 2026
- Net proceeds from offering expected to be approximately $35.6 million after fees and expenses
- Series B Preferred Stock issued with stated value of $100 per share, convertible into common stock
Why it matters
Nuburu faces potential delisting from NYSE American but retains a cure path via reverse stock split and a review/appeal process; the timing alongside a major financing suggests the company has capital to execute the compliance plan, though successful delisting prevention depends on stock price recovery and shareholder approval of any additional amendments.
Developing story
- NT 10-Q
- 8-Kthis filing
Share
Derived from 8-K filed 2026-07-21. Not investment advice. View the source filing on SEC.gov →